Prescient Therapeutics Limited Share Price
Stocks
PTX
AU000000PTX3
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Australian S.E.
23:21:55 09/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.0565 AUD | +0.89% |
|
+13.00% | -32.74% |
| 10-22 | Prescient Therapeutics Limited Announces Management Changes, Effective October 23, 2026 | CI |
| 10-21 | Prescient Therapeutics Limited - Special Call |
| Market Cap | 64.06M 44.34M 39.51M 36.33M 32.96M 62.6M 4.16B 434M 173M 2.23B 166M 163M 7.01B | P/E 2025 |
-4.84x | P/E 2026 | -8.94x |
|---|---|---|---|---|---|
| Enterprise Value | 55.23M 38.23M 34.07M 31.33M 28.42M 53.97M 3.59B 374M 149M 1.92B 144M 140M 6.04B | EV / Sales 2025 |
6.54x | EV / Sales 2026 | 16x |
| Free-Float |
94.89% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PTX | Delayed | |
Deutsche Boerse AG
| UDD | Delayed |
Last Transcript: Prescient Therapeutics Limited
| 1 day | +0.89% | ||
| 1 week | +13.00% | ||
| Current month | +6.60% | ||
| 1 month | -14.39% | ||
| 3 months | -33.53% | ||
| 6 months | +5.61% | ||
| Current year | -32.74% |
| 1 week | 0.05 |  | 0.06 |
| 1 month | 0.05 | | 0.07 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.04 | | 0.12 |
| 3 years | 0.04 | | 0.12 |
| 5 years | 0.04 | | 0.27 |
| 10 years | 0.02 | | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 19/01/2025 | |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | - |
Rosalind Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 12/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
James Campbell
CHM | Chairman | - | 29/03/2025 |
Allen Ebens
BRD | Director/Board Member | - | 31/05/2020 |
Ellen Feigal
BRD | Director/Board Member | 71 | 14/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Buy | Director | 200,000 | 0.0175% | ||
| 30/09/26 | Buy | Chairman | 153,846 | 0.0134% | ||
| 30/09/26 | Buy | Director | 76,923 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.89% | +13.00% | +17.71% | +2.73% | 42.48M | |
| +2.24% | +5.83% | +58.47% | +65.65% | 66.7B | |
| +4.66% | +5.77% | +16.93% | +82.87% | 56.88B | |
| -0.60% | +2.36% | +24.32% | +97.19% | 56.53B | |
| +2.55% | +12.69% | +30.43% | +108.45% | 46.49B | |
| +2.58% | +4.31% | +32.49% | +39.59% | 44.8B | |
| +4.09% | +4.62% | +228.06% | +845.00% | 41.59B | |
| -0.47% | +9.60% | +27.53% | +52.88% | 35.35B | |
| +3.80% | -6.42% | +98.16% | +68.09% | 33.29B | |
| +1.48% | +3.13% | -38.80% | +388.84% | 25.1B | |
| Average | +2.12% | +3.15% | +49.53% | +175.13% | 41B | |
| Weighted average by Cap. | +2.29% | +3.97% | +53.74% | +173.17% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 4.36M 3.02M 2.69M 2.47M 2.24M 4.26M 283M 29.53M 11.79M 151M 11.32M 11.08M 476M | 3.45M 2.39M 2.13M 1.96M 1.78M 3.37M 224M 23.4M 9.34M 120M 8.97M 8.78M 377M |
| Net income | -7.32M -5.07M -4.52M -4.15M -3.77M -7.16M -476M -49.64M -19.81M -255M -19.03M -18.62M -801M | -7M -4.85M -4.32M -3.97M -3.6M -6.84M -455M -47.47M -18.95M -243M -18.2M -17.81M -766M |
| Net Debt | -6.93M -4.79M -4.27M -3.93M -3.56M -6.77M -450M -46.96M -18.74M -241M -18M -17.61M -758M | -8.83M -6.11M -5.44M -5.01M -4.54M -8.62M -574M -59.83M -23.88M -307M -22.93M -22.44M -965M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/11/26 | A$0.0565 | +0.89% | 62,358 |
| 09/11/26 | A$0.0560 | +3.70% | 264,067 |
| 06/11/26 | A$0.0540 | +1.89% | 266,748 |
| 05/11/26 | A$0.0530 | +3.92% | 149,755 |
| 04/11/26 | A$0.0510 | -3.77% | 141,578 |
- Stock Market
- Stocks
- PTX Stock
Select your edition
All financial news and data tailored to specific country editions
